User profiles for "author:D Chemtob"
 | Daniel ChemtobDirector of the Department of Tuberculosis and AIDS, Israel Ministry of Health Verified email at mail.huji.ac.il Cited by 2675 |
Towards tuberculosis elimination: an action framework for low-incidence countries
…, F Castelli, R Centis, D Chemtob… - European …, 2015 - Eur Respiratory Soc
This paper describes an action framework for countries with low tuberculosis (TB) incidence
(< 100 TB cases per million population) that are striving for TB elimination. The framework …
(< 100 TB cases per million population) that are striving for TB elimination. The framework …
HIV outbreaks among people who inject drugs in Europe, North America, and Israel
Summary During 2011–16, HIV outbreaks occurred among people who inject drugs (PWID)
in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel …
in Canada (southeastern Saskatchewan), Greece (Athens), Ireland (Dublin), Israel (Tel …
Tuberculosis contact investigation in low prevalence countries: a European consensus
…, M Kamphorst, I Abubakar, GH Bothamley, D Chemtob… - 2010 - Eur Respiratory Soc
Contact investigation to identify individuals with tuberculosis and latent infection with
Mycobacterium tuberculosis is an important component of tuberculosis control in low …
Mycobacterium tuberculosis is an important component of tuberculosis control in low …
[HTML][HTML] A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis …
…, KA Rumman, E Altpeter, D Chemtob… - BMC infectious …, 2011 - Springer
Background Tuberculosis (TB) in migrants is an ongoing challenge in several low TB
incidence countries since a large proportion of TB in these countries occurs in migrants from …
incidence countries since a large proportion of TB in these countries occurs in migrants from …
[HTML][HTML] Availability and costs of medicines for the treatment of tuberculosis in Europe
…, AM McLaughlin, M Fitzgibbon, D Chemtob… - Clinical microbiology …, 2023 - Elsevier
Objectives To evaluate the access to comprehensive diagnostics and novel antituberculosis
medicines in European countries. Methods We investigated the access to genotypic and …
medicines in European countries. Methods We investigated the access to genotypic and …
Mortality after anti-tuberculosis treatment completion: results of long-term follow-up
J Shuldiner, A Leventhal, D Chemtob… - … International Journal of …, 2016 - ingentaconnect.com
BACKGROUND: Mycobacterium tuberculosis affects the lung parenchyma even after
successful treatment. OBJECTIVE: To assess long-term mortality in a cohort of individuals …
successful treatment. OBJECTIVE: To assess long-term mortality in a cohort of individuals …
[HTML][HTML] Impact of COVID-19 & response measures on HIV-HCV prevention services and social determinants in people who inject drugs in 13 sites with recent HIV …
…, A Arble, N Berndt, A Bosch, S Buskin, D Chemtob… - AIDS and Behavior, 2023 - Springer
HIV/HCV prevention among people who inject drugs (PWID) is of key public health
importance. We aimed to assess the impact of COVID-19 and associated response …
importance. We aimed to assess the impact of COVID-19 and associated response …
Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes
…, N Cedar, E Rorman, D Chemtob - … of tuberculosis and …, 2014 - ingentaconnect.com
SETTING: All culture-positive tuberculosis (TB) isolates in Israel. OBJECTIVES: To outline
the magnitude of drug-resistant TB in Israel, describe treatment outcomes and identify risk …
the magnitude of drug-resistant TB in Israel, describe treatment outcomes and identify risk …
Genotypic variation of HIV-1 reverse transcriptase and protease: comparative analysis of clade C and clade B
Z Grossman, N Vardinon, D Chemtob, ML Alkan… - Aids, 2001 - journals.lww.com
Objective To compare drug-resistant variants from untreated (naive) and treated patients
infected with clade B or C virus. Methods Consecutive samples (165) from patients …
infected with clade B or C virus. Methods Consecutive samples (165) from patients …
The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort study
C Ganzel, B Silverman, D Chemtob… - Leukemia & …, 2019 - Taylor & Francis
Patients with cancer are at high risk for tuberculosis (TB). This study combined the Israeli
databases of cancer and TB and examined the development of TB among all newly …
databases of cancer and TB and examined the development of TB among all newly …